Penumbra, Inc. (PEN)
Largest Insider Buys in Sector
PEN Stock Price History Chart
PEN Stock Performance
About Penumbra, Inc.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the …
Insider Activity of Penumbra, Inc.
Over the last 12 months, insiders at Penumbra, Inc. have bought $0 and sold $29.65M worth of Penumbra, Inc. stock.
On average, over the past 5 years, insiders at Penumbra, Inc. have bought $0 and sold $28.73M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 700 shares for transaction amount of $109,480 was made by O'Rourke Bridget (director) on 2018‑05‑25.
List of Insider Buy and Sell Transactions, Penumbra, Inc.
| 2024-12-20 | Sale | CEO and President | 15,000 0.0391% | $242.96 | $3.64M | -0.82% | ||
| 2024-12-02 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $244.49 | $146,697 | +0.16% | ||
| 2024-12-02 | Sale | Chief Accounting Officer | 654 0.0017% | $243.01 | $158,929 | +0.16% | ||
| 2024-11-29 | Sale | Chief Accounting Officer | 1,798 0.0047% | $242.56 | $436,123 | +0.38% | ||
| 2024-11-20 | Sale | CEO and President | 15,000 0.039% | $237.28 | $3.56M | +2.32% | ||
| 2024-11-18 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $239.74 | $143,843 | -0.82% | ||
| 2024-10-21 | Sale | CEO and President | 15,000 0.0382% | $204.56 | $3.07M | +17.12% | ||
| 2024-10-02 | Sale | director | 166 0.0004% | $190.83 | $31,678 | +22.70% | ||
| 2024-10-01 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0015% | $190.76 | $114,456 | +23.43% | ||
| 2024-10-01 | Sale | director | 170 0.0004% | $193.93 | $32,968 | +23.43% | ||
| 2024-09-20 | Sale | CEO and President | 15,000 0.0392% | $197.71 | $2.97M | +21.05% | ||
| 2024-09-04 | Sale | director | 782 0.002% | $204.11 | $159,614 | +8.67% | ||
| 2024-09-03 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $206.22 | $123,733 | +3.12% | ||
| 2024-08-23 | Sale | CEO and President | 28,380 0.0707% | $203.37 | $5.77M | -0.70% | ||
| 2024-08-22 | Sale | CEO and President | 1,620 0.0042% | $200.00 | $324,000 | +5.86% | ||
| 2024-08-13 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $175.98 | $105,587 | 0.00% | ||
| 2024-07-17 | Sale | CEO and President | 15,000 0.0386% | $202.52 | $3.04M | -0.02% | ||
| 2024-07-01 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $179.20 | $107,519 | 0.00% | ||
| 2024-07-01 | Sale | director | 170 0.0005% | $179.99 | $30,598 | 0.00% | ||
| 2024-06-03 | Sale | EVP, Gen. Counsel & Secretary | 600 0.0016% | $188.90 | $113,339 | +6.38% |
Insider Historical Profitability
| Evans Robert D. | EVP, Gen. Counsel & Secretary | 15667 0.0408% | $241.14 | 1 | 35 | +44.13% |
| O'Rourke Bridget | director | 4214 0.011% | $241.14 | 1 | 23 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $1.3B | 14.98 | 5.81M | +0.28% | +$3.58M | 0.09 | |
| BlackRock | $906.39M | 10.48 | 4.06M | +1.52% | +$13.59M | 0.02 | |
| The Vanguard Group | $823.68M | 9.52 | 3.69M | +0.89% | +$7.27M | 0.02 | |
| T. Rowe Price | $675.3M | 7.81 | 3.03M | -2.54% | -$17.58M | 0.08 | |
| State Street | $268.78M | 3.11 | 1.2M | +9.37% | +$23.04M | 0.01 |